News In Brief Business and Economy
News In Brief Business and Economy

Infosys To Buy Denmark-Based BASE Life Science For Rs 875 Cr

Share Us

456
Infosys To Buy Denmark-Based BASE Life Science For Rs 875 Cr
14 Jul 2022
5 min read

News Synopsis

Infosys has announced that it would buy BASE Life Science, a company based in Denmark, for around 110 million euros (roughly Rs. 875 crore). The acquisition will expand Infosys' knowledge in the life sciences industry and expand its presence in Europe. "With the help of cloud-based industry solutions, this purchase grows Infosys' already robust life sciences expertise while also enhancing our reach in the Nordics and across Europe.

Ravi Kumar S, the president of Infosys, said, "We are thrilled to welcome BASE life science and its leadership team into the Infosys family. The transaction is anticipated to be completed in the second quarter of this fiscal year.

Domain professionals with knowledge of business, medicine, digital marketing, clinical, regulatory, and quality are brought to Infosys by BASE.

"BASE is at the forefront of the most recent technological advancements and trends thanks to a team of data science experts on its side. With a heavy emphasis on data and artificial intelligence, it can bridge and combine business logic with technology to produce insights that lead to better health outcomes.

"The company has about 200 of the finest, multidisciplinary industry experts across Denmark, Switzerland, UK, Germany, France, Italy, and a nearshore technology hub in Spain, the filing said. The BASE wants to expand its portfolio into Consumer Health, Animal Health, Med Tech, and Genomics segments.